{"id":37270,"date":"2009-11-06T07:46:08","date_gmt":"2009-11-06T12:46:08","guid":{"rendered":"http:\/\/www.pehub.com\/?p=54903"},"modified":"2009-11-06T07:46:08","modified_gmt":"2009-11-06T12:46:08","slug":"light-sciences-raises-35-million-bridge","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/37270","title":{"rendered":"Light Sciences Raises $35 Million Bridge"},"content":{"rendered":"<p><strong>Light Sciences Oncology Inc.<\/strong>, a Snoqualmie, Wash.-based developer of light-activated treatments for solid tumors, has raised $35 million in debt and option financing, according to a regulatory filing. VentureWire refers to the round as &#8220;bridge financing&#8221; as it considers a second stab at the IPO market. LSO had\u00a0filed for an IPO in early 2006, but pulled it in 2008 citing\u00a0&#8221;unfavorable market conditions.&#8221;<\/p>\n<p>At the time, LSO\u00a0had raised nearly $99 million in VC funding since 2005, from firms like Essex Woodlands Health Ventures, Scandinavian Life Science Venture, Novo AS, New Science Ventures, China Industrial Development Bank and Johnson &amp; Johnson Development Corp. <a href=\"http:\/\/www.lsoncology.com\">www.lsoncology.com<\/a><\/p>\n<p><a href=\"http:\/\/sharethis.com\/item?&#038;wp=2.6.2&amp;publisher=cc2b1207-de99-4484-bf7a-c797973e9397&amp;title=Light+Sciences+Raises+%2435+Million+Bridge&amp;url=http%3A%2F%2Fwww.pehub.com%2F54903%2Flight-sciences-raises-35-million-bridge%2F\">ShareThis<\/a><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/JYu9psyuzJ4uXIqMUtTrLg9jWaY\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/JYu9psyuzJ4uXIqMUtTrLg9jWaY\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/JYu9psyuzJ4uXIqMUtTrLg9jWaY\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/JYu9psyuzJ4uXIqMUtTrLg9jWaY\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=Ava5TNb4g7I:sfDmNpK7CWQ:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=Ava5TNb4g7I:sfDmNpK7CWQ:dnMXMwOfBR0\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=dnMXMwOfBR0\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=Ava5TNb4g7I:sfDmNpK7CWQ:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=Ava5TNb4g7I:sfDmNpK7CWQ:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=Ava5TNb4g7I:sfDmNpK7CWQ:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=7Q72WNTAKBA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=Ava5TNb4g7I:sfDmNpK7CWQ:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=Ava5TNb4g7I:sfDmNpK7CWQ:V_sGLiPBpWU\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=Ava5TNb4g7I:sfDmNpK7CWQ:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=qj6IDK7rITs\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=Ava5TNb4g7I:sfDmNpK7CWQ:l6gmwiTKsz0\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=l6gmwiTKsz0\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/pehub\/news\/all\/~4\/Ava5TNb4g7I\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Light Sciences Oncology Inc., a Snoqualmie, Wash.-based developer of light-activated treatments for solid tumors, has raised $35 million in debt and option financing, according to a regulatory filing. VentureWire refers to the round as &#8220;bridge financing&#8221; as it considers a second stab at the IPO market. LSO had\u00a0filed for an IPO in early 2006, but [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-37270","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/37270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=37270"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/37270\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=37270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=37270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=37270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}